• AstraZeneca signs deal to sell commercial rights for Seloken in Europe pharmaceutical-technology
    May 27, 2017
    AstraZeneca has entered an agreement to provide the commercial rights for Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments in Eur
  • AstraZeneca enters agreement with Recordati for Seloken in Europe europeanpharmaceuticalreview
    May 25, 2017
    AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treat
PharmaSources Customer Service